Effect [qlco]
Raloxifene [orch, phsu]
serum triglycerides [lbpr]
postmenopausal [tmco]
Women [popg]
influential [idcn]
Predisposing Factors [tmco]
Hypertriglyceridaemia [fndg]
Background [cnce]
Estrogen [horm, phsu, strd]
Increase [ftcn]
Serum triglyceride levels [lbpr]
Induce [ftcn]
Hypertriglyceridaemia [fndg]
Susceptible [ftcn]
Women [popg]
Effect [qlco]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulator [horm, phsu]
serum triglyceride [lbpr]
Not [ftcn]
Study [mnob]
Detail [qlco]
Objective [inpr]
Purpose [ftcn]
Study [mnob]
To [qlco]
Effect [qlco]
Raloxifene [orch, phsu]
Serum triglyceride levels [lbpr]
postmenopausal [tmco]
Women [popg]
Osteoporosis [dsyn]
Including [ftcn]
Predisposing Factors [tmco]
Hypertriglyceridaemia [fndg]
Methods [inpr]
Fasting [fndg]
Serum triglyceride levels [lbpr]
Assessed [acty]
months [tmco]
postmenopausal [tmco]
Women [popg]
Mean [qnco]
Age [orga]
Assigned [ftcn]
placebo [topp]
Raloxifene [orch, phsu]
mg/d [qnco]
Osteoporosis [dsyn]
treatment [ftcn]
Trial [resa]
Over [spco]
months [tmco]
postmenopausal [tmco]
Women [popg]
Osteoporosis [dsyn]
Mean [qnco]
Age [orga]
Assigned [ftcn]
placebo [topp]
Raloxifene [orch, phsu]
mg/d [qnco]
Osteoporosis [dsyn]
prevention trials [resa]
Result [ftcn]
Osteoporosis [dsyn]
treatment [ftcn]
Trial [resa]
median [spco]
serum concentration [qnco]
Triglyceride [bacs, lipd]
Decreased [qnco]
Group [idcn]
placebo [topp]
Group [idcn]
placebo [topp]
Raloxifene [orch, phsu]
mg/d [qnco]
Raloxifene [orch, phsu]
mg/d [qnco]
P NOS [aapp, imft]
Osteoporosis [dsyn]
prevention trials [resa]
Percentage [qnco]
Change [ftcn]
median [spco]
serum concentration [qnco]
Triglyceride [bacs, lipd]
Not [ftcn]
Different [qlco]
Treatments [topp]
P NOS [aapp, imft]
Women [popg]
degrees [qnco]
Hypertriglyceridaemia [fndg]
baseline [bodm]
mmol/L [qnco]
median [spco]
serum triglyceride [lbpr]
Level [qlco]
End [spco]
Study [mnob]
Decreased [qnco]
baseline [bodm]
Group [idcn]
Treatments [topp]
P NOS [aapp, imft]
Equal [qlco]
Effect [qlco]
Raloxifene [orch, phsu]
serum triglyceride [lbpr]
Level [qlco]
Not [ftcn]
Age [orga]
Smoking [inbe]
Status [qlco]
ALCOHOL [orch]
Presence [topp]
Diabetes [dsyn]
P NOS [aapp, imft]
Equal [qlco]
Interaction [ftcn]
Women [popg]
Highest [qlco]
Body Mass Index [diap]
kg-m [qnco]
Raloxifene [orch, phsu]
Increased [qnco]
Serum triglyceride levels [lbpr]
Compared [acty]
placebo [topp]
placebo [topp]
Raloxifene [orch, phsu]
mg/d [qnco]
Raloxifene [orch, phsu]
mg/d [qnco]
P NOS [aapp, imft]
Absolute [qlco]
Increase [ftcn]
baseline [bodm]
Raloxifene [orch, phsu]
Sub- [spco]
Group [idcn]
mmol/dL [qnco]
mg% [qnco]
Conclusions [idcn]
Raloxifene [orch, phsu]
Not [ftcn]
Increase [ftcn]
serum triglyceride [lbpr]
postmenopausal [tmco]
Women [popg]
Overall [inpr]
Women [popg]
Elevated [qlco]
Triglyceride level [lbtr]
Evidence [ftcn]
Diabetes [dsyn]
baseline [bodm]
Triglyceride level [lbtr]
Increased [qnco]
Slightly [idcn]
Statistically [ocdi]
Women [popg]
Upper [spco]
Body Mass Index [diap]
treated [topp]
Raloxifene [orch, phsu]
